Cardiac Markers Market: Global Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Cardiac Markers Market: By Test Type (NT-proBNP Test, Troponin I & T, GDF-15, CK-MB, hsCR Others) Type of Testing (Laboratory Testing, Point of Care Testing) and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

1. Executive Summary
2. Global Cardiac Markers Market Introduction
2.1. Global Cardiac Markers Market – Taxonomy
2.2. Global Cardiac Markers Market –Definitions
2.2.1. By Test Type
2.2.2. By Type of Testing
2.2.3. By Region
3. Global Cardiac Markers Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Cardiac Markers Market Dynamic Factors – Impact Analysis
3.6. Global Cardiac Markers Market – Competition Landscape
4. Global Cardiac Markers Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Cardiac Markers Market, By Test Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. NT-proBNP Test
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Troponin I & T
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. GDF-15
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. hsCRP
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Cardiac Markers Market, By Type of Testing, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1. Laboratory Testing
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Point of Care Testing
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Cardiac Markers Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1. North America
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Cardiac Markers Market – Opportunity Analysis Index, By Test Type, Type of Testing,  and Region, 2022 – 2028
8. North America Cardiac Markers Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1. Test Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. NT-proBNP Test
8.1.2. Troponin I & T
8.1.3. GDF-15
8.1.4. CK-MB
8.1.5. hsCRP
8.1.6. Others
8.2. Type of Testing Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Laboratory Testing
8.2.2. Point of Care Testing
8.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. USA
8.3.2. Canada
8.4. North America Cardiac Markers Market – Opportunity Analysis Index, By Test Type, Type of Testing,  and Country, 2022 – 2028
8.5. North America Cardiac Markers Market Dynamics – Trends
9. Europe Cardiac Markers Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1. Test Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. NT-proBNP Test
9.1.2. Troponin I & T
9.1.3. GDF-15
9.1.4. CK-MB
9.1.5. hsCRP
9.1.6. Others
9.2. Type of Testing Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Laboratory Testing
9.2.2. Point of Care Testing
9.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Rest of Europe
9.4. Europe Cardiac Markers Market – Opportunity Analysis Index, By Test Type, Type of Testing,  and Country, 2022 – 2028
9.5. Europe Cardiac Markers Market Dynamics – Trends
10. Asia-Pacific Cardiac Markers Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1. Test Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. NT-proBNP Test
10.1.2. Troponin I & T
10.1.3. GDF-15
10.1.4. CK-MB
10.1.5. hsCRP
10.1.6. Others
10.2. Type of Testing Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Laboratory Testing
10.2.2. Point of Care Testing
10.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Cardiac Markers Market – Opportunity Analysis Index, By Test Type, Type of Testing,  and Country, 2022 – 2028
10.5. Asia-Pacific Cardiac Markers Market Dynamics – Trends
11. Latin America Cardiac Markers Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
11.1. Test Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. NT-proBNP Test
11.1.2. Troponin I & T
11.1.3. GDF-15
11.1.4. CK-MB
11.1.5. hsCRP
11.1.6. Others
11.2. Type of Testing Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Laboratory Testing
11.2.2. Point of Care Testing
11.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Rest of Latin America
11.4. Latin America Cardiac Markers Market – Opportunity Analysis Index, By Test Type, Type of Testing,  and Country, 2022 – 2028
11.5. Latin America Cardiac Markers Market Dynamics – Trends
12. Middle East and Africa Cardiac Markers Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. Test Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. NT-proBNP Test
12.1.2. Troponin I & T
12.1.3. GDF-15
12.1.4. CK-MB
12.1.5. hsCRP
12.1.6. Others
12.2. Type of Testing Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Laboratory Testing
12.2.2. Point of Care Testing
12.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Cardiac Markers Market – Opportunity Analysis Index, By Test Type, Type of Testing,  and Country, 2022 – 2028
12.5. MEA Cardiac Markers Market Dynamics – Trends
13. Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Test Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. F. Hoffman-LA Roche
13.2.2. Abbott Laboratories
13.2.3. Siemens
13.2.4. Danaher Corporation
13.2.5. Biomerieux
13.2.6. Ortho Clinical Diagnostics
13.2.7. Randox Laboratories
14. Research Methodology
15. Key Assumptions and Acronyms

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Company Profile

  • Hoffman-LA Roche
  • Abbott Laboratories
  • Siemens
  • Danaher Corporation
  • Biomerieux
  • Ortho Clinical Diagnostics
  • Randox Laboratories

Description

1. Executive Summary
2. Global Cardiac Markers Market Introduction
2.1. Global Cardiac Markers Market – Taxonomy
2.2. Global Cardiac Markers Market –Definitions
2.2.1. By Test Type
2.2.2. By Type of Testing
2.2.3. By Region
3. Global Cardiac Markers Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Cardiac Markers Market Dynamic Factors – Impact Analysis
3.6. Global Cardiac Markers Market – Competition Landscape
4. Global Cardiac Markers Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Cardiac Markers Market, By Test Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. NT-proBNP Test
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Troponin I & T
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. GDF-15
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. hsCRP
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Cardiac Markers Market, By Type of Testing, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1. Laboratory Testing
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Point of Care Testing
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Cardiac Markers Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1. North America
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Cardiac Markers Market – Opportunity Analysis Index, By Test Type, Type of Testing,  and Region, 2022 – 2028
8. North America Cardiac Markers Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1. Test Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. NT-proBNP Test
8.1.2. Troponin I & T
8.1.3. GDF-15
8.1.4. CK-MB
8.1.5. hsCRP
8.1.6. Others
8.2. Type of Testing Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Laboratory Testing
8.2.2. Point of Care Testing
8.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. USA
8.3.2. Canada
8.4. North America Cardiac Markers Market – Opportunity Analysis Index, By Test Type, Type of Testing,  and Country, 2022 – 2028
8.5. North America Cardiac Markers Market Dynamics – Trends
9. Europe Cardiac Markers Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1. Test Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. NT-proBNP Test
9.1.2. Troponin I & T
9.1.3. GDF-15
9.1.4. CK-MB
9.1.5. hsCRP
9.1.6. Others
9.2. Type of Testing Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Laboratory Testing
9.2.2. Point of Care Testing
9.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Rest of Europe
9.4. Europe Cardiac Markers Market – Opportunity Analysis Index, By Test Type, Type of Testing,  and Country, 2022 – 2028
9.5. Europe Cardiac Markers Market Dynamics – Trends
10. Asia-Pacific Cardiac Markers Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1. Test Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. NT-proBNP Test
10.1.2. Troponin I & T
10.1.3. GDF-15
10.1.4. CK-MB
10.1.5. hsCRP
10.1.6. Others
10.2. Type of Testing Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Laboratory Testing
10.2.2. Point of Care Testing
10.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Cardiac Markers Market – Opportunity Analysis Index, By Test Type, Type of Testing,  and Country, 2022 – 2028
10.5. Asia-Pacific Cardiac Markers Market Dynamics – Trends
11. Latin America Cardiac Markers Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
11.1. Test Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. NT-proBNP Test
11.1.2. Troponin I & T
11.1.3. GDF-15
11.1.4. CK-MB
11.1.5. hsCRP
11.1.6. Others
11.2. Type of Testing Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Laboratory Testing
11.2.2. Point of Care Testing
11.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Rest of Latin America
11.4. Latin America Cardiac Markers Market – Opportunity Analysis Index, By Test Type, Type of Testing,  and Country, 2022 – 2028
11.5. Latin America Cardiac Markers Market Dynamics – Trends
12. Middle East and Africa Cardiac Markers Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. Test Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. NT-proBNP Test
12.1.2. Troponin I & T
12.1.3. GDF-15
12.1.4. CK-MB
12.1.5. hsCRP
12.1.6. Others
12.2. Type of Testing Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Laboratory Testing
12.2.2. Point of Care Testing
12.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Cardiac Markers Market – Opportunity Analysis Index, By Test Type, Type of Testing,  and Country, 2022 – 2028
12.5. MEA Cardiac Markers Market Dynamics – Trends
13. Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Test Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. F. Hoffman-LA Roche
13.2.2. Abbott Laboratories
13.2.3. Siemens
13.2.4. Danaher Corporation
13.2.5. Biomerieux
13.2.6. Ortho Clinical Diagnostics
13.2.7. Randox Laboratories
14. Research Methodology
15. Key Assumptions and Acronyms

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX